Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triple negative breast cancer: unmet medical needs.
Pal SK, Childs BH, Pegram M. Pal SK, et al. Among authors: pegram m. Breast Cancer Res Treat. 2011 Feb;125(3):627-36. doi: 10.1007/s10549-010-1293-1. Epub 2010 Dec 15. Breast Cancer Res Treat. 2011. PMID: 21161370 Free PMC article. Review.
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
Knutson KL, Clynes R, Shreeder B, Yeramian P, Kemp KP, Ballman K, Tenner KS, Erskine CL, Norton N, Northfelt D, Tan W, Calfa C, Pegram M, Mittendorf EA, Perez EA. Knutson KL, et al. Among authors: pegram m. Cancer Res. 2016 Jul 1;76(13):3702-10. doi: 10.1158/0008-5472.CAN-15-3091. Epub 2016 Apr 20. Cancer Res. 2016. PMID: 27197192 Free PMC article. Clinical Trial.
Trastuzumab emtansine for HER2-positive advanced breast cancer.
Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh DY, Diéras V, Guardino E, Fang L, Lu MW, Olsen S, Blackwell K; EMILIA Study Group. Verma S, et al. Among authors: pegram m. N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1. N Engl J Med. 2012. PMID: 23020162 Free PMC article. Clinical Trial.
Targeting HER2 Epitopes.
Pal SK, Pegram M. Pal SK, et al. Among authors: pegram m. Semin Oncol. 2006 Aug;33(4):386-91. doi: 10.1053/j.seminoncol.2006.04.004. Semin Oncol. 2006. PMID: 16890794 Review.
151 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page